Skip navigation

Dynamic Dialogue Through Timely Updates and Unparalleled Insights for Strategic and Operational Excellence

May 21-23, 2018
  • Orlando, FL

DAY ONE — MONDAY, MAY 21, 2018

1:00 Conference Registration

2:00   CHOOSE FROM TWO SUMMITS (1-2)

1 GOVERNMENT PRICING AND REPORTING 101 BOOT CAMP

For newcomers and seasoned pricing, contracting and reporting professionals looking for a refresher course, this 101 Boot Camp is designed to lay the groundwork and instill a fundamental understanding on the key components of government pricing and reporting.

Miree Lee, MS, MBA
Bio/Pharma Pricing Consultant
M. Lee Consulting, LLC

Stephanie Kupski
Director, Pricing and Contracts
Horizon Pharma

Paula Martins
Director, Commercial Operations
Helsinn Therapeutics (U.S.), Inc.

Susan Leveille
Director, Contract Operations
Jazz Pharmaceuticals

2 SENIOR EXECUTIVE THINK TANK

This all new Senior Executive GP Think Tank invites managementlevel professionals with pricing, reporting and contracting responsibilities to join an engaging and dynamic discussion. The content and talking points are driven by participants who are surveyed in advance, and represent topical themes that are presenting challenges across policy, methodology as well as operations and systems. Collaborate with your industry counterparts to discuss the opportunities and challenges that we all face across the industry, and align on how to bring a comprehensive perspective to your company’s strategy and operations.

Chris Cobourn
Managing Director
KPMG LLP

Greg Wiefel
Director
KPMG LLP

William Lit
Director
KPMG LLP

Lynn Buhl
Director
KPMG LLP

3:00   Networking and Refreshment Break

3:30   CHOOSE FROM TWO SUMMITS (3-4)

3 FEDERAL CONTRACTING AND FSS FUNDAMENTALS DEEP DIVE

This Summit addresses the basics of the Veteran’s Health Care Act (VHCA) and FSS pricing requirements. Gain an understanding of key concepts and requirements to benchmark government pricing processes against.

Cathy Zhang
Associate Director, Government Contracts
Eisai Inc.

Lisa McNair
Manager, Contracting,
Pricing and Government Reporting
Indivior Inc.

Gregory Madden
Principal
Orlaithe Consulting LLC

4 340B PROGRAM EVOLUTION AND OVERSIGHT MASTER CLASS

As regulations evolve impacting the 340B Program, pharmaceutical companies are faced with uncertainty on how to strengthen program compliance and integrity. This Summit breaks down impending regulations and oversight activity and provides key concepts to ensure compliance.

Sabrina Aery
Director, 340B Compliance and
State Policy Value, Access & Payment
Bristol-Myers Squibb

Lynn Lewis, Director
Government Programs,
Data Acquisition and Integrity
IQVIA

5:30   CLOSE OF SUMMITS AND DAY ONE

HOSTED BY: OPENING NIGHT RECEPTION immediately following the final session on day one

DAY TWO — TUESDAY, MAY 22, 2018

7:15

Main Conference Registration and Continental Breakfast

8:15

CBI Welcome

Elise Guerin Saas
Senior Program Director
CBI, a division of UBM Americas

8:20

Chairman’s Welcome and Opening Remarks

Rajeev Devgan
Director, Government Rebate Operations
Johnson & Johnson Health Care Systems Inc.

8:30

HEALTHCARE INNOVATION SPOTLIGHT The Future of Value-Based Arrangements in Healthcare

Gregory Daniel, PhD, MPH, RPh
Deputy Director, Policy
Duke Margolis Center for Health Policy

9:15

Technology and Life Sciences Convergence — Connecting GP Data in New Ways

Mel Walker
Principal, Deloitte Risk and Financial Advisory
Deloitte & Touche LLP

Guy Merritt
Managing Director, Deloitte Risk and Financial Advisory
Deloitte & Touche LLP

10:00

Time to Rethink 340B? Preserve the Program by Addressing its Abuses

John Shakow
Partner
King & Spalding

10:45

Networking and Refreshment Break

11:15

340B Program Update and Hot Topics

Mike Benedict, RPh, MS
Vice President, Operations
Apexus

Marcy Imada
Principal, Deloitte Risk and Financial Advisory
Deloitte & Touche LLP

12:00

PANEL DISCUSSION The Latest Developments in State Pricing Transparency and Disclosure

Moderator:

Meenakshi Datta
Partner
Sidley Austin LLP

Panelists:

Jack Geisser
Director, Healthcare Policy, Medicaid and State Initiatives
BIO

Stephanie Trunk
Partner
Arent Fox

Douglas Helling
Senior Counsel, Market Access and Pricing
UCB, Inc.

Josh O’Harra
Assistant General Counsel
Eli Lilly & Co

12:45

Networking Luncheon

2:00 CHOOSE FROM THREE STRATEGY STREAMS (I-III)

STRATEGY STREAM I STRATEGIC PRICING AND TRANSPARENCY

2:00

Stream Chair’s Welcome

2:10

State-by-State Breakdown —
What You Need to Know to Ensure Reporting Compliance

William Sarraille
Partner
Sidley Austin LLP

2:55

Tracking Legislative Activities and Price Reporting Requirements

Michael Kurland
Vice President, Market Access and Government Programs
Dohmen Life Science Services

MRafael Angulo
Director, Government Pricing
Novartis

3:40

Open Roundtable Q&A

STRATEGY STREAM II STATUTORY REPORTING REQUIREMENTS

2:00

Stream Chair’s Welcome

Brian McCartney
Senior Director, Pricing and Government Reporting
AstraZeneca

2:05

Trends of Integrated Systems and the Impact to Class of Trade

Ryan McKinney
Senior Principal
Cumberland Consulting

2:45

PANEL Reasonable Assumptions —
Navigate Murky Waters to Ensure Compliance

PANELISTS:

Heather Dixson
Director, Government Pricing and Payer Strategy
Lilly USA, LLC

Kathleen Dynan Black
Director, Government Strategy
Pfizer Inc

Debbie Walters-Francique
Vice President, Assistant General Counsel
Pfizer Inc

3:25

State Invoicing and Dispute Resolution

Maury Anderson
Director, Pharmacy Rebate Operations
Magellan Rx Management

Diane Weisbrod Bayer
Director, Operations, Government Data Resources
IQVIA

STRATEGY STREAM III FINANCE AND COMPLIANCE OPERATIONS

2:00

Stream Chair’s Introduction

Donna White
Vice President, Contracts and Compliance
Chiesi USA, Inc.

2:05

Ensuring Compliant Partnering —
How to Effectively Monitor 3P Vendor Data

Michelle Scheid Meyer
Director, Industry Specialty Services – Government Pricing, Strategy and Compliance
BDO

2:45

Roadmap to Revenue and Launching —
GTN and Government Programs Early Checklist

Jennifer English
Director, Market Access, Pricing and Gross-to-Net Financial Operations
Insmed Incorporated

Patrick Coyle
Vice President
FP&A, Insmed Incorporated

3:25

Product Bundling and Implications to Government Pricing, Compliance and Revenue Recognition

Larry Breen
Director
FP&A, Sunovion Pharmaceuticals

4:00

Networking and Refreshment Break

4:30 CHOOSE FROM THREE WORKSHOPS (A-C)

A GROSS-TO-NET STRATEGIES AND SOLUTIONS

Tom Evegan
Managing Director
Cumberland Consulting Group

Josef Magpantay
Principal
Cumberland Consulting Group

Marijo Bustos
Director, Government Programs and Commercial Compliance
Prometic Biotherapeutics Inc.

B PRODUCT ACQUISITION DUE DILIGENCE AND GP CONSIDERATIONS

Randall Perry
Vice President, Industry Relations, Integrichain;
Co-Founder, MCT

C GENERIC INFLATION PENALTY OPERATIONAL GUIDANCE

Lisa Clayton
Associate Director, Government Reporting
West-Ward Pharmaceuticals

5:15

Close of Workshops and Day Two

HOSTED BY: COCKTAIL RECEPTION immediately following the final session on day two

DAY THREE — WEDNESDAY, MAY 23, 2018

8:00

Networking Breakfast

8:30

Chairman’s Welcome

Glen Huttar
Director, Government Pricing
Johnson & Johnson Health Care Systems Inc.

8:40

PANEL DISCUSSION Where Are We Now? — The State of Medicare and Drug Coverage

MODERATOR:

Michael Flinn
Principal
Cumberland Consulting

PANELISTS:

Amy Demske
Director
Bristol-Myers Squibb

Thomas Barker
Partner, Foley Hoag LLP;
former General Counsel, U.S. Department of Health and Human Services

Kristin Wolff
Director, Global Government Affairs and Public Policy
bluebird bio

9:25

CMS ADDRESS CMS Policy Initiatives and Operational Updates

John Coster, PhD, RPh
Director, Division of Pharmacy, Center for Medicaid and CHIP Services
CMS (Invited)

10:00

OIG UPDATE OIG Work Plan and 2018 Initiatives

David Tawes
Regional Inspector General, Department of Health and Human Services
OIG

10:30

PANEL DISCUSSION State Spotlight — Update on Medicaid and State Programs

PANELISTS:

Stefanie Nadeau
Director, Office of MaineCare Services
Maine Department of Health and Human Services

Mike Randol
Medicaid Director
State of Iowa, Department of Human Services and Iowa Medicaid Enterprise

Shannon Sprout
Deputy Administrator
Nevada Department of Health and Human Services

11:15

Networking and Refreshment Break

11:45 CHOOSE FROM THREE WORKSHOPS (D-F)

D VALUE-BASED FRAMEWORKS AND GOVERNMENT PRICING STRATEGIES

Amy Garabedian
Associate General Counsel
Spark Therapeutics

Sarah Pitluck
Head, Global Pricing and Reimbursement
Spark Therapeutics

E MEDICAID AND GP REPORTING — BUILD OR BUY?

Alexandra Bonelli
Principal
EY

Jack Simbach
Senior Manager
EY

F MEDICAID SUPPLEMENTAL REBATES — CURRENT EVENTS AND OPERATIONAL EFFECTIVENESS

Jennifer Lospinoso
Managing Director
KPMG LLP

Shevonne Taylor
Senior Manager, Contract Development
Gilead Sciences

12:30

Networking Luncheon

1:30

FIRESIDE CHAT Legal and Compliance Closing Bell

MODERATOR:

Rick Zimmerer
Partner
KPMG LLP

PANELISTS:

John Shakow
Partner
King & Spalding

Trevor Wear
Partner
Sidley Austin LLP

Stephanie Trunk
Partner
Arent Fox

2:15

Chairman’s Closing Remarks and Key Takeaways

Glen Huttar
Director, Government Pricing
Johnson & Johnson Health Care Systems Inc.

2:30

Close of Conference

20th Annual Medicaid and Government Pricing Congress

Dynamic Dialogue Through Timely Updates and Unparalleled Insights for Strategic and Operational Excellence

DAY ONE — MONDAY, MAY 21, 2018

1:00 Conference Registration

2:00   CHOOSE FROM TWO SUMMITS (1-2)

1 GOVERNMENT PRICING AND REPORTING 101 BOOT CAMP

For newcomers and seasoned pricing, contracting and reporting professionals looking for a refresher course, this 101 Boot Camp is designed to lay the groundwork and instill a fundamental understanding on the key components of government pricing and reporting.

Miree Lee, MS, MBA
Bio/Pharma Pricing Consultant
M. Lee Consulting, LLC

Stephanie Kupski
Director, Pricing and Contracts
Horizon Pharma

Paula Martins
Director, Commercial Operations
Helsinn Therapeutics (U.S.), Inc.

Susan Leveille
Director, Contract Operations
Jazz Pharmaceuticals

2 SENIOR EXECUTIVE THINK TANK

This all new Senior Executive GP Think Tank invites managementlevel professionals with pricing, reporting and contracting responsibilities to join an engaging and dynamic discussion. The content and talking points are driven by participants who are surveyed in advance, and represent topical themes that are presenting challenges across policy, methodology as well as operations and systems. Collaborate with your industry counterparts to discuss the opportunities and challenges that we all face across the industry, and align on how to bring a comprehensive perspective to your company’s strategy and operations.

Chris Cobourn
Managing Director
KPMG LLP

Greg Wiefel
Director
KPMG LLP

William Lit
Director
KPMG LLP

Lynn Buhl
Director
KPMG LLP

3:00   Networking and Refreshment Break

3:30   CHOOSE FROM TWO SUMMITS (3-4)

3 FEDERAL CONTRACTING AND FSS FUNDAMENTALS DEEP DIVE

This Summit addresses the basics of the Veteran’s Health Care Act (VHCA) and FSS pricing requirements. Gain an understanding of key concepts and requirements to benchmark government pricing processes against.

Cathy Zhang
Associate Director, Government Contracts
Eisai Inc.

Lisa McNair
Manager, Contracting,
Pricing and Government Reporting
Indivior Inc.

Gregory Madden
Principal
Orlaithe Consulting LLC

4 340B PROGRAM EVOLUTION AND OVERSIGHT MASTER CLASS

As regulations evolve impacting the 340B Program, pharmaceutical companies are faced with uncertainty on how to strengthen program compliance and integrity. This Summit breaks down impending regulations and oversight activity and provides key concepts to ensure compliance.

Sabrina Aery
Director, 340B Compliance and
State Policy Value, Access & Payment
Bristol-Myers Squibb

Lynn Lewis, Director
Government Programs,
Data Acquisition and Integrity
IQVIA

5:30   CLOSE OF SUMMITS AND DAY ONE

HOSTED BY: OPENING NIGHT RECEPTION immediately following the final session on day one

DAY TWO — TUESDAY, MAY 22, 2018

7:15

Main Conference Registration and Continental Breakfast

8:15

CBI Welcome

Elise Guerin Saas
Senior Program Director
CBI, a division of UBM Americas

8:20

Chairman’s Welcome and Opening Remarks

Rajeev Devgan
Director, Government Rebate Operations
Johnson & Johnson Health Care Systems Inc.

8:30

HEALTHCARE INNOVATION SPOTLIGHT The Future of Value-Based Arrangements in Healthcare

Gregory Daniel, PhD, MPH, RPh
Deputy Director, Policy
Duke Margolis Center for Health Policy

9:15

Technology and Life Sciences Convergence — Connecting GP Data in New Ways

Mel Walker
Principal, Deloitte Risk and Financial Advisory
Deloitte & Touche LLP

Guy Merritt
Managing Director, Deloitte Risk and Financial Advisory
Deloitte & Touche LLP

10:00

Time to Rethink 340B? Preserve the Program by Addressing its Abuses

John Shakow
Partner
King & Spalding

10:45

Networking and Refreshment Break

11:15

340B Program Update and Hot Topics

Mike Benedict, RPh, MS
Vice President, Operations
Apexus

Marcy Imada
Principal, Deloitte Risk and Financial Advisory
Deloitte & Touche LLP

12:00

PANEL DISCUSSION The Latest Developments in State Pricing Transparency and Disclosure

Moderator:

Meenakshi Datta
Partner
Sidley Austin LLP

Panelists:

Jack Geisser
Director, Healthcare Policy, Medicaid and State Initiatives
BIO

Stephanie Trunk
Partner
Arent Fox

Douglas Helling
Senior Counsel, Market Access and Pricing
UCB, Inc.

Josh O’Harra
Assistant General Counsel
Eli Lilly & Co

12:45

Networking Luncheon

2:00 CHOOSE FROM THREE STRATEGY STREAMS (I-III)

STRATEGY STREAM I STRATEGIC PRICING AND TRANSPARENCY

2:00

Stream Chair’s Welcome

2:10

State-by-State Breakdown —
What You Need to Know to Ensure Reporting Compliance

William Sarraille
Partner
Sidley Austin LLP

2:55

Tracking Legislative Activities and Price Reporting Requirements

Michael Kurland
Vice President, Market Access and Government Programs
Dohmen Life Science Services

MRafael Angulo
Director, Government Pricing
Novartis

3:40

Open Roundtable Q&A

STRATEGY STREAM II STATUTORY REPORTING REQUIREMENTS

2:00

Stream Chair’s Welcome

Brian McCartney
Senior Director, Pricing and Government Reporting
AstraZeneca

2:05

Trends of Integrated Systems and the Impact to Class of Trade

Ryan McKinney
Senior Principal
Cumberland Consulting

2:45

PANEL Reasonable Assumptions —
Navigate Murky Waters to Ensure Compliance

PANELISTS:

Heather Dixson
Director, Government Pricing and Payer Strategy
Lilly USA, LLC

Kathleen Dynan Black
Director, Government Strategy
Pfizer Inc

Debbie Walters-Francique
Vice President, Assistant General Counsel
Pfizer Inc

3:25

State Invoicing and Dispute Resolution

Maury Anderson
Director, Pharmacy Rebate Operations
Magellan Rx Management

Diane Weisbrod Bayer
Director, Operations, Government Data Resources
IQVIA

STRATEGY STREAM III FINANCE AND COMPLIANCE OPERATIONS

2:00

Stream Chair’s Introduction

Donna White
Vice President, Contracts and Compliance
Chiesi USA, Inc.

2:05

Ensuring Compliant Partnering —
How to Effectively Monitor 3P Vendor Data

Michelle Scheid Meyer
Director, Industry Specialty Services – Government Pricing, Strategy and Compliance
BDO

2:45

Roadmap to Revenue and Launching —
GTN and Government Programs Early Checklist

Jennifer English
Director, Market Access, Pricing and Gross-to-Net Financial Operations
Insmed Incorporated

Patrick Coyle
Vice President
FP&A, Insmed Incorporated

3:25

Product Bundling and Implications to Government Pricing, Compliance and Revenue Recognition

Larry Breen
Director
FP&A, Sunovion Pharmaceuticals

4:00

Networking and Refreshment Break

4:30 CHOOSE FROM THREE WORKSHOPS (A-C)

A GROSS-TO-NET STRATEGIES AND SOLUTIONS

Tom Evegan
Managing Director
Cumberland Consulting Group

Josef Magpantay
Principal
Cumberland Consulting Group

Marijo Bustos
Director, Government Programs and Commercial Compliance
Prometic Biotherapeutics Inc.

B PRODUCT ACQUISITION DUE DILIGENCE AND GP CONSIDERATIONS

Randall Perry
Vice President, Industry Relations, Integrichain;
Co-Founder, MCT

C GENERIC INFLATION PENALTY OPERATIONAL GUIDANCE

Lisa Clayton
Associate Director, Government Reporting
West-Ward Pharmaceuticals

5:15

Close of Workshops and Day Two

HOSTED BY: COCKTAIL RECEPTION immediately following the final session on day two

DAY THREE — WEDNESDAY, MAY 23, 2018

8:00

Networking Breakfast

8:30

Chairman’s Welcome

Glen Huttar
Director, Government Pricing
Johnson & Johnson Health Care Systems Inc.

8:40

PANEL DISCUSSION Where Are We Now? — The State of Medicare and Drug Coverage

MODERATOR:

Michael Flinn
Principal
Cumberland Consulting

PANELISTS:

Amy Demske
Director
Bristol-Myers Squibb

Thomas Barker
Partner, Foley Hoag LLP;
former General Counsel, U.S. Department of Health and Human Services

Kristin Wolff
Director, Global Government Affairs and Public Policy
bluebird bio

9:25

CMS ADDRESS CMS Policy Initiatives and Operational Updates

John Coster, PhD, RPh
Director, Division of Pharmacy, Center for Medicaid and CHIP Services
CMS (Invited)

10:00

OIG UPDATE OIG Work Plan and 2018 Initiatives

David Tawes
Regional Inspector General, Department of Health and Human Services
OIG

10:30

PANEL DISCUSSION State Spotlight — Update on Medicaid and State Programs

PANELISTS:

Stefanie Nadeau
Director, Office of MaineCare Services
Maine Department of Health and Human Services

Mike Randol
Medicaid Director
State of Iowa, Department of Human Services and Iowa Medicaid Enterprise

Shannon Sprout
Deputy Administrator
Nevada Department of Health and Human Services

11:15

Networking and Refreshment Break

11:45 CHOOSE FROM THREE WORKSHOPS (D-F)

D VALUE-BASED FRAMEWORKS AND GOVERNMENT PRICING STRATEGIES

Amy Garabedian
Associate General Counsel
Spark Therapeutics

Sarah Pitluck
Head, Global Pricing and Reimbursement
Spark Therapeutics

E MEDICAID AND GP REPORTING — BUILD OR BUY?

Alexandra Bonelli
Principal
EY

Jack Simbach
Senior Manager
EY

F MEDICAID SUPPLEMENTAL REBATES — CURRENT EVENTS AND OPERATIONAL EFFECTIVENESS

Jennifer Lospinoso
Managing Director
KPMG LLP

Shevonne Taylor
Senior Manager, Contract Development
Gilead Sciences

12:30

Networking Luncheon

1:30

FIRESIDE CHAT Legal and Compliance Closing Bell

MODERATOR:

Rick Zimmerer
Partner
KPMG LLP

PANELISTS:

John Shakow
Partner
King & Spalding

Trevor Wear
Partner
Sidley Austin LLP

Stephanie Trunk
Partner
Arent Fox

2:15

Chairman’s Closing Remarks and Key Takeaways

Glen Huttar
Director, Government Pricing
Johnson & Johnson Health Care Systems Inc.

2:30

Close of Conference